RESUMO
Iron deficiency anemia affects many pregnant women and young infants worldwide. The health impact is significant, given iron's known role in many body functions, including oxidative and lipid metabolism, protein synthesis and brain neurochemistry. The following research determined if (1)H NMR spectroscopy-based metabolomic analysis of cerebrospinal fluid (CSF) could detect the adverse influence of early life iron deficiency on the central nervous system. Using a controlled dietary model in 43 infant primates, distinct differences were found in spectra acquired at 600 MHz from the CSF of anemic monkeys. Three metabolite ratios, citrate/pyruvate, citrate/lactate and pyruvate/glutamine ratios, differed significantly in the iron deficient infant and then normalized following the consumption of dietary iron and improvement of clinical indices of anemia in the heme compartment. This distinctive metabolomic profile associated with anemia in the young infant indicates that CSF can be employed to track the neurological effects of iron deficiency and benefits of iron supplementation.
Assuntos
Anemia Ferropriva/líquido cefalorraquidiano , Encéfalo/metabolismo , Metabolismo Energético , Deficiências de Ferro , Metabolômica , Anemia Ferropriva/sangue , Animais , Ácido Cítrico/líquido cefalorraquidiano , Feminino , Glutamina/líquido cefalorraquidiano , Ácido Láctico/líquido cefalorraquidiano , Macaca mulatta/crescimento & desenvolvimento , Imageamento por Ressonância Magnética , Ácido Pirúvico/líquido cefalorraquidianoRESUMO
OBJECTIVES: Determinations of cerebrospinal fluid (CSF) lactate and pyruvate concentrations and CSF lactate:pyruvate (L/P) ratios are important in several clinical settings, yet published normative data have significant limitations. We sought to determine a large dataset of stringently-defined normative data for CSF lactate and pyruvate concentrations and CSF L/P ratios. DESIGN AND METHODS: We evaluated data from 627 patients who had determinations of CSF lactate and/or CSF pyruvate from 2001 to 2011 at the Cleveland Clinic. Inclusion in the normal reference population required normal CSF cell counts, glucose and protein and routine serum chemistries and absence of progressive brain disorder, epilepsy, or seizure within 24h. Brain MRI, if done, showed no evidence of tumor, acute changes or basal ganglia abnormality. CSF cytology, CSF alanine and immunoglobulin levels, and oligoclonal band analysis were required to be normal, if done. Various inclusion/exclusion criteria were compared. RESULTS: 92 patients fulfilled inclusion/exclusion criteria for a reference population. The 95% central intervals (2.5%-97.5%) for CSF lactate and pyruvate levels were 1.01-2.09mM and 0.03-0.15mM, respectively, and 9.05-26.37 for CSF L/P. There were no significant gender-related differences of CSF lactate or pyruvate concentrations or of CSF L/P. Weak positive correlations between the concentration of CSF lactate or pyruvate and age were noted. CONCLUSIONS: Using stringent inclusion/exclusion criteria, we determined normative data for CSF lactate and pyruvate concentrations and CSF L/P ratios in a large, well-characterized reference population. Normalcy of routine CSF and blood analytes are the most important parameters in determining reference intervals for CSF lactate and pyruvate.
Assuntos
Ácido Láctico/líquido cefalorraquidiano , Ácido Pirúvico/líquido cefalorraquidiano , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Valores de ReferênciaRESUMO
BACKGROUND: This study examines the inflammatory response via interleukin-6 (IL-6) in aneurysmal subarachnoid hemorrhage (aSAH) patients and its association with their clinical course (occurrence of acute focal neurological deficits, AFND; and delayed cerebral ischemia, DCI). METHODS: A total of 38 consecutive aSAH patients were studied prospectively within 14 days after admission and classified as asymptomatic (n = 9; WFNS grade 1 (1-2), median and quartiles) and symptomatic (n = 29; WFNS grade 4 (2-5)); the latter presenting with AFND (n = 13), DCI (n = 10) or both (n = 6). Levels of pro-inflammatory cytokine IL-6 were determined in cerebral extracellular fluid (ECF, using cerebral microdialysis), cerebrospinal fluid (CSF) and plasma for 10 days after aSAH. Additionally, C-reactive protein (CRP) levels were measured in plasma. RESULTS: High IL-6 levels in CSF, ECF and plasma were found in all patients, reflecting a pronounced local inflammatory response after aSAH, followed only in symptomatic patients by a delayed systemic inflammation (CRP P < 0.025, days 7-9 after aSAH). In all compartments, IL-6 levels appeared to be higher in symptomatic patients, accompanied also by a higher ECF lactate-pyruvate ratio (P = 0.04). Cerebral, but not plasma IL-6, levels were indicative of the development of DCI in symptomatic patients (ECF P = 0.003; CSF P = 0.001). CONCLUSIONS: A pronounced initial cerebral inflammatory state was observed in patients of all WFNS grades, suggesting that IL-6 elevations are not necessarily detrimental. Cerebral, but not plasma IL-6, levels were predictive of the development of delayed ischemic deficits in symptomatic patients, suggesting that CSF or ECF are the best sampling media for future studies.
Assuntos
Encefalite/líquido cefalorraquidiano , Encefalite/imunologia , Interleucina-6/líquido cefalorraquidiano , Hemorragia Subaracnóidea/líquido cefalorraquidiano , Hemorragia Subaracnóidea/imunologia , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Isquemia Encefálica/sangue , Isquemia Encefálica/líquido cefalorraquidiano , Isquemia Encefálica/imunologia , Proteína C-Reativa/metabolismo , Cuidados Críticos/métodos , Líquido Extracelular/imunologia , Líquido Extracelular/metabolismo , Feminino , Humanos , Interleucina-6/sangue , Ácido Láctico/líquido cefalorraquidiano , Masculino , Microdiálise , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Ácido Pirúvico/líquido cefalorraquidiano , Hemorragia Subaracnóidea/sangueAssuntos
Encéfalo/metabolismo , Circulação Cerebrovascular , Parada Circulatória Induzida por Hipotermia Profunda , Metabolismo Energético , Perfusão/métodos , Animais , Biomarcadores/líquido cefalorraquidiano , Barreira Hematoencefálica/metabolismo , Temperatura Corporal , Encéfalo/patologia , Ponte Cardiopulmonar , Parada Circulatória Induzida por Hipotermia Profunda/efeitos adversos , Glucose/líquido cefalorraquidiano , Glicerol/líquido cefalorraquidiano , Ácido Láctico/líquido cefalorraquidiano , Microdiálise , Modelos Animais , Monitorização Intraoperatória , Perfusão/efeitos adversos , Ácido Pirúvico/líquido cefalorraquidiano , Fatores de TempoRESUMO
Hypothermic arrest and selective antegrade cerebral perfusion (SACP) is widely used during aortic arch surgery. The microdialysis technique monitors biomarkers of cellular metabolism and cellular integrity over time. In this study, the cerebral changes during hypothermic circulatory arrest (HCA) at 20 degrees C and HCA with SACP at two different temperatures, 20 and 28 degrees C, were monitored. Twenty-three pigs were divided into three groups. A microdialysis probe was fixated into the forebrain. Circulatory arrest started at a brain and body temperature of 20 degrees C or 28 degrees C. Arrest with/without cerebral perfusion (flow 10 ml/kg, max carotid artery pressure 70 mmHg) lasted for 80 min followed by reperfusion and rewarming during 40 min and an observation period of 120 min. The microdialysis markers were registered at six time-points. The lactate/pyruvate ratio (L/P ratio) and the lactate/glucose ratio (L/G ratio) increased significantly (P<0.05), during arrest, in the HCA group. The largest increase of glycerol was found in the group with tepid cerebral perfusion (28 degrees C) and the HCA group (P<0.05). This study supports the use of SACP over arrest. It also suggests that cerebral metabolism and cellular membrane integrity may be better preserved with SACP at 20 degrees C compared to 28 degrees C.
Assuntos
Temperatura Corporal , Circulação Cerebrovascular , Parada Circulatória Induzida por Hipotermia Profunda , Microdiálise , Perfusão/métodos , Prosencéfalo/metabolismo , Animais , Biomarcadores/líquido cefalorraquidiano , Ponte Cardiopulmonar , Parada Circulatória Induzida por Hipotermia Profunda/efeitos adversos , Metabolismo Energético , Glucose/líquido cefalorraquidiano , Glicerol/líquido cefalorraquidiano , Ácido Láctico/líquido cefalorraquidiano , Modelos Animais , Monitorização Intraoperatória , Perfusão/efeitos adversos , Prosencéfalo/patologia , Ácido Pirúvico/líquido cefalorraquidiano , Sus scrofa , Fatores de TempoRESUMO
Cerebral microdialysis is an invasive technique for neurochemical monitoring that has been established for neuro-critical disorders such as subarachnoid hemorrhage and severe brain injury. We present data on cerebral microdialysis in stroke patients which were obtained in an ongoing study supported by the German Ministry for Education and Research. So far, 50 patients have been included who required critical care due to massive stroke of the middle cerebral artery territory. By correlating the microdialysis results with follow-up CT scans, we could define the neurochemical characteristics of three different brain compartments: (1) noninfarcted brain tissue with normal microdialysis values, (2) brain areas adjacent to the infarct core which were not hypodense in CT scans but caused reversible neurochemical alterations, and (3) the infarct core with massive concentration changes which did not normalize over the measuring period of 3 to 5 days. Microdialysis values averaged over time and correlated with initial PET scans helped to describe neurochemical predictors of a malignant, i.e., life-threatening, space-occupying course of the ischemic stroke. We discuss the value of this method in guiding therapy and predicting clinical outcome in the context of other neurological critical care disorders and describe the pros and cons of cerebral microdialysis as an invasive monitoring technique.